Raymond James Financial Services Advisors’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3,878
| Closed | -$71.3K | – | 3407 |
|
2024
Q1 | $71.3K | Sell |
3,878
-65
| -2% | -$1.2K | ﹤0.01% | 3255 |
|
2023
Q4 | $62.6K | Sell |
3,943
-13
| -0.3% | -$206 | ﹤0.01% | 3168 |
|
2023
Q3 | $74.5K | Buy |
3,956
+796
| +25% | +$15K | ﹤0.01% | 3099 |
|
2023
Q2 | $71.4K | Sell |
3,160
-323
| -9% | -$7.3K | ﹤0.01% | 3096 |
|
2023
Q1 | $88.5K | Sell |
3,483
-200
| -5% | -$5.08K | ﹤0.01% | 3055 |
|
2022
Q4 | $55.7K | Sell |
3,683
-751
| -17% | -$11.4K | ﹤0.01% | 3071 |
|
2022
Q3 | $56K | Buy |
4,434
+97
| +2% | +$1.23K | ﹤0.01% | 3061 |
|
2022
Q2 | $42K | Buy |
4,337
+23
| +0.5% | +$223 | ﹤0.01% | 3081 |
|
2022
Q1 | $72K | Buy |
4,314
+562
| +15% | +$9.38K | ﹤0.01% | 3126 |
|
2021
Q4 | $95K | Sell |
3,752
-715
| -16% | -$18.1K | ﹤0.01% | 3112 |
|
2021
Q3 | $200K | Sell |
4,467
-250
| -5% | -$11.2K | ﹤0.01% | 2975 |
|
2021
Q2 | $191K | Buy |
4,717
+382
| +9% | +$15.5K | ﹤0.01% | 3017 |
|
2021
Q1 | $231K | Sell |
4,335
-139
| -3% | -$7.41K | ﹤0.01% | 2813 |
|
2020
Q4 | $179K | Sell |
4,474
-430
| -9% | -$17.2K | ﹤0.01% | 2748 |
|
2020
Q3 | $280K | Sell |
4,904
-197
| -4% | -$11.2K | ﹤0.01% | 2311 |
|
2020
Q2 | $376K | Buy |
+5,101
| New | +$376K | ﹤0.01% | 2095 |
|
2020
Q1 | – | Sell |
-6,211
| Closed | -$477K | – | 2429 |
|
2019
Q4 | $477K | Buy |
6,211
+1,079
| +21% | +$82.9K | ﹤0.01% | 2011 |
|
2019
Q3 | $205K | Sell |
5,132
-1,244
| -20% | -$49.7K | ﹤0.01% | 2488 |
|
2019
Q2 | $214K | Sell |
6,376
-885
| -12% | -$29.7K | ﹤0.01% | 2491 |
|
2019
Q1 | $385K | Sell |
7,261
-6,233
| -46% | -$330K | ﹤0.01% | 2055 |
|
2018
Q4 | $634K | Buy |
13,494
+2,866
| +27% | +$135K | ﹤0.01% | 1520 |
|
2018
Q3 | $935K | Buy |
10,628
+2,197
| +26% | +$193K | ﹤0.01% | 1501 |
|
2018
Q2 | $877K | Buy |
8,431
+4,981
| +144% | +$518K | ﹤0.01% | 1504 |
|
2018
Q1 | $276K | Buy |
3,450
+1,961
| +132% | +$157K | ﹤0.01% | 2077 |
|
2017
Q4 | $203K | Buy |
1,489
+290
| +24% | +$39.5K | ﹤0.01% | 2255 |
|
2017
Q3 | $194K | Buy |
1,199
+325
| +37% | +$52.6K | ﹤0.01% | 2284 |
|
2017
Q2 | $131K | Buy |
+874
| New | +$131K | ﹤0.01% | 2305 |
|